Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder
- 11 May 2021
- journal article
- research article
- Published by Taylor & Francis in Cognitive Neuropsychiatry
- Vol. 26 (4) , 257-272
Abstract
Cognitive impairment is among the core features of schizophrenia. In a healthy population, the cognitive deficit is often linked with cannabis abuse, and although the same would be expected in pati...Keywords
Funding Information
- NPU I n. LO1611 (LO1611)
- Ministry of Education, Youth and Sports
- MEYS
This publication has 59 references indexed in Scilit:
- Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic SymptomsNeuropsychopharmacology, 2010
- The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode SampleSchizophrenia Bulletin, 2010
- International Consensus Study of Antipsychotic DosingAmerican Journal of Psychiatry, 2010
- High-potency cannabis and the risk of psychosisThe British Journal of Psychiatry, 2009
- Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysisSchizophrenia Bulletin, 2009
- Cannabis use and cognition in schizophreniaFrontiers in Human Neuroscience, 2009
- Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosisPsychological Medicine, 2007
- Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis UseTherapeutic Drug Monitoring, 2006
- Pharmacokinetics and Pharmacodynamics of CannabinoidsClinical Pharmacokinetics, 2003
- Rey complex figure test under four different administration proceduresThe Clinical Neuropsychologist, 1995